Haemonetics Corp

HAE

Company Profile

  • Business description

    Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

  • Contact

    125 Summer Street
    BostonMA02110
    USA

    T: +1 781 848-7100

    E: [email protected]

    https://www.haemonetics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2027

    Employees

    3,023

Stocks News & Analysis

stocks

Investors overlooking ASX share’s potential

International expansion is a distraction from valuable local business.
stocks

Cerebras sees blockbuster demand, setting stage for US AI IPO frenzy

The chipmaker’s IPO priced at $185, well above its initial range, and opened trading at an eye-popping $350.
stocks

What did Morningstar subscribers buy and sell in April?

How the most traded shares in April stack up against our analysts views.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,870.6046.70-0.52%
CAC 407,952.55129.72-1.61%
DAX 4023,950.57505.69-2.07%
Dow JONES (US)49,526.17537.29-1.07%
FTSE 10010,195.37177.56-1.71%
HKSE25,962.73426.31-1.62%
NASDAQ26,225.14410.08-1.54%
Nikkei 22561,409.291,244.76-1.99%
NZX 50 Index12,965.0160.06-0.46%
S&P 5007,408.5092.74-1.24%
S&P/ASX 2008,630.8042.70-0.49%
SSE Composite Index4,135.3942.53-1.02%

Market Movers